You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2-specific T cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoma Trial in Houston (Autologous HER2-specific T cells, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Sarcoma
  • Autologous HER2-specific T cells
  • +3 more
  • Houston, Texas
  • +1 more
Nov 21, 2022

Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Houston (HER2-specific T cells)

Recruiting
  • Brain Tumor, Recurrent
  • Brain Tumor, Refractory
  • HER2-specific T cells
  • Houston, Texas
  • +1 more
May 3, 2022

Ependymoma Trial in New York (HER2 Specific CAR T Cell)

Recruiting
  • Ependymoma
  • HER2 Specific CAR T Cell
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 6, 2022

Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)

Recruiting
  • Bladder Cancer
  • +9 more
  • CAdVEC
  • Houston, Texas
    Baylor St. Luke's Medical Center
Feb 17, 2022

Peritoneal Carcinoma Metastatic, Pleural Effusion, Malignant Trial in Chengdu (Dual-targeting HER2 and PD-L1 CAR-T cells)

Active, not recruiting
  • Peritoneal Carcinoma Metastatic
  • Pleural Effusion, Malignant
  • Dual-targeting HER2 and PD-L1 CAR-T cells
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 21, 2021

HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)

Not yet recruiting
  • HER2 Positive Advanced Solid Tumors
  • HypoSti.CAR-HER2 T cells
  • +2 more
  • (no location specified)
Jan 12, 2023

Breast Cancer, Metastatic HER2-negative Breast Trial in United States (Cyclophosphamide, Mesothelin-targeted T cells, AP1903)

Active, not recruiting
  • Breast Cancer
  • Metastatic HER2-negative Breast
  • Basking Ridge, New Jersey
  • +6 more
Mar 21, 2022

CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

Recruiting
  • Central Nervous System Tumor, Pediatric
  • +8 more
  • HER2-specific chimeric antigen receptor (CAR) T cell
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and

Not yet recruiting
  • HER2+ Advanced Breast Cancer
  • Other Solid Tumors
  • ADCC-R-Epo-R T-cells + Trastuzumab
  • +2 more
  • (no location specified)
Aug 31, 2023

Solid Tumor Trial in Shenyang (Intravenous infusion anti-HER2-CAR-T cell)

Not yet recruiting
  • Solid Tumor
  • Intravenous infusion anti-HER2-CAR-T cell
  • Shenyang, Liaoning, China
    Phase I Clinical Trials Center Of The First Hospital of China Me
Oct 30, 2023

B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic

Terminated
  • B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
  • +16 more
  • Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 28, 2021

HER-2 Gene Amplification, HER2-positive Gastric Cancer, HER2-positive Breast Cancer Trial in United States (chimeric antigen

Recruiting
  • HER-2 Gene Amplification
  • +4 more
  • chimeric antigen receptor (CAR) T cell therapy
  • Duarte, California
  • +6 more
Aug 10, 2022

Breast Cancer Trial in Detroit (biological, drug, other)

Terminated
Has Results
  • Breast Cancer
  • HER2Bi-armed activated T cells
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Nov 29, 2022

Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

Recruiting
  • Malignant Neoplasm
  • +4 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)

Terminated
  • Breast Cancer Female
  • Leptomeningeal Metastases
  • HER2 BATs
  • Charlottesville, Virginia
    University of Virginia
Dec 15, 2022

Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Autologous Mesothelin-specific TCR-T Cells
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 31, 2023

Solid Tumor Trial (HER2-E-CART cells)

Not yet recruiting
  • Solid Tumor
  • HER2-E-CART cells
  • (no location specified)
Feb 16, 2023

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

Not yet recruiting
  • CMV Infection
  • +2 more
  • Virus specific T cells
  • (no location specified)
Oct 4, 2023

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

Antigen-specific T Cells in Antisynthetase Syndrome and

Not yet recruiting
  • Antisynthetase Syndrome
  • BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT
  • Dijon, France
  • +5 more
Aug 2, 2023

Metastatic Breast Cancer Trial in Charlottesville (HER2 BATs with Pembrolizumab)

Recruiting
  • Metastatic Breast Cancer
  • HER2 BATs with Pembrolizumab
  • Charlottesville, Virginia
    Ashley Donihee
Jan 18, 2023

Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Neuroblastoma
  • GINAKIT Cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Jan 18, 2023

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023